End-Stage Kidney Disease
Empagliflozin lowers kidney disease progression, cardiovascular death in patients with CKD
ORLANDO —Empagliflozin reduced kidney disease progression and cardiovascular death in patients with chronic kidney disease, according to data presented at ASN Kidney Week.
FDA grants IND clearance to Transcenta for IgA nephropathy treatment
The FDA granted investigational new drug clearance to Transcenta Holding Limited for TST004, its humanized monoclonal antibody that attacks the enzyme contributing to IgA nephropathy development, according to a press release.
Infants with severe kidney disease experience high risk for early growth failure
Infants with severe congenital anomalies of the kidney and urinary tract, including those who do not require dialysis, are at risk for early growth failure, according to data published in the Journal of Renal Nutrition.
Anemia correlates with cardiovascular disease, lower eGFR, additional adverse outcomes
Anemia independently correlated with lower eGFR and an increased risk of end-stage kidney disease, cardiovascular disease, coronary heart disease, stroke, heart failure and death, according to recently published data.
Patient, physician education remains a barrier to home dialysis implementation
In order for patients to be ready to take on home dialysis, physicians must be properly trained and know how to prepare patients, according to a presenter at the International Conference on Dialysis.
Experts recommend claims-based approach when studying PD-associated peritonitis
A Medicare claims-based approach offers a “promising framework” for researchers studying peritoneal dialysis-associated peritonitis, according to data published in the American Journal of Kidney Diseases.
Barriers to living donor kidney transplantation include poor communication, training
A survey of Canadian health professionals revealed poor communication and a lack of education and training as barriers to living donor kidney transplantation, according to data published in Kidney International Reports.
Intradialytic exercise, protein consumption does not prevent uremic toxin removal
Exercise and consuming protein during hemodialysis does not compromise uremic toxin removal in patients with end-stage renal disease, according to data published in the Journal of Renal Nutrition.
Deteriorating renal function strong predictor of mortality after PCI
Among adults undergoing PCI, even mild to moderate chronic kidney disease is associated with decreased survival at 1 year in a dose-dependent manner, researchers reported.
Patients with history of autoimmune disease have fewer AAV relapses
Patients with ANCA-associated vasculitis who have a history of autoimmune disease prior to diagnosis may have fewer relapses following remission, according to data published in Clinical and Experimental Rheumatology.